About Gerresheimer Gerresheimer is an innovative system and solution provider and global partner for the pharma, biotech and cosmetics industries. The company offers a comprehensive portfolio of pharmaceutical packaging, drug delivery systems, medical devices and digital solutions. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. With around 13,400 employees and over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets ****** Über Gerresheimer Gerresheimer ist als innovativer System- und Lösungsanbieter der globale Partner der Pharma-, Biotech- und Kosmetikindustrie. Das Unternehmen bietet ein umfassendes Portfolio an pharmazeutischen Primärverpackungen, Verabreichungssystemen für Medikamente und digitalen Lösungen. Gerresheimer sorgt dafür, dass Medikamente sicher zum Patienten gelangen und zuverlässig verabreicht werden können. Mit rund 13.400 Mitarbeitenden, und über 40 Produktions-standorten in 16 Ländern in Europa, Amerika und Asien ist Gerresheimer global präsent und produziert vor Ort für die regionalen Märkte
Unlock the market timeline & signal feed
31 signals in the last 90 days.
The order this company entered each market — oldest to newest
Quality Control Associate
Plant Director
Sign up to see the full signal feed
How Gerresheimer's international expansion compares to its competitors
GerresheimerYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 GerresheimerYou | 3 | 1 | -97% | 31 | 35 |
Werkstudent / Praktikant - Plant Supplier Quality (m/w/d)
View postingPfreimd, Bavaria, Germany · Part-time · yesterday
Werkstudent - Treasury, Tax & Insurance (m/w/d)
View postingRegensburg, Bavaria, Germany · yesterday
Plant P&O Manager
View postingBergantino, Veneto, Italy · 3d ago
Join to Learn How Advances in IVIs Support Patient Safety
Ended
Join for Insights Into the Future of Intravitreal Injections
Ended
Join to Learn How User Research Shapes IVI Device Design
EndedSchott Pharma shares hit record low of €23.60 after annual results and outlook, closing down 5.6% at €24.54.
Trump's trade war halts billions in M&A and IPOs, including StubHub, Klarna, and eToro. Markets tumble, wiping out $5.4 trillion in value.
German stocks fell due to Middle East tensions and upcoming US interest rate decision. DAX lost 0.50% to 23,317.81 points.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Gerresheimer's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
